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ABSTRACT
Objectives: Choline and folate metabolism disturbances may be involved in the occurrence of intrauterine fetal death (IUFD). 
The proper activity of this metabolism could be determined by genetic variants involved in choline pathway e.g. CHKA 
(gene encoding choline kinase α), PCYT1A (gene encoding CCTα) and CHDH (gene encoding choline dehydrogenase). Our 
study aimed at determining the genotype and allele frequencies of CHKA rs7928739, PCYT1A rs712012, PCYT1A rs7639752, 
CHDH rs893363 and CHDH rs2289205 polymorphisms in mothers with IUFD occurrence.
Material and methods: The study involved 76 mothers with IUFD occurrence and 215 mothers of healthy children. Genetic 
analysis was performed with the use of PCR/RFLP method.
Results: The frequency of genotypes and alleles of studied polymorphisms was similar in both groups. The study revealed 
no association of PCYT1A, CHKA and CHDH polymorphisms in analysed groups of women. While evaluating the co-existence 
of analysed polymorphisms statistically significant correlation was revealed. Co-existence of CHKA rs7928739 AC/CHDH 
rs2289205 AA genotypes was observed statistically more frequently in the study group than in the control group (p = 0,031). 
Conclusions: There is no correlation between single CHKA rs7928739, PCYT1A rs712012, PCYT1A rs7639752, CHDH 
rs893363 and CHDH rs2289205 polymorphisms and the incidence of intrauterine fetal death. However, revealed statisti-
cally significant difference between co-existence of CHKA rs7928739 AC/CHDH rs2289205 AA genotypes between study 
groups suggest the need of further analysis.
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INTRODUCTION
Choline is a nutrient essential for proper fetal and pla-
cental development. Choline acts as a methyl group do-
nor in the reaction of methylation of homocysteine into 
methionine. The reduced supply of choline-derived methyl 
donors may impair Hcy remethylation, leading to elevations 
in Hcy, and perturb folate mediated one-carbon metabo-
lism (e.g., nucleotide biosynthesis and cellular methylation 
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reactions) [1, 2]. Choline is used for production of phos-
phatidylcholine (PC) and sphingomyelin in the cycle called 
cytidine — diphosphocholine (CDP-choline) pathway. Phos-
phatidylcholine and sphingomyelin are essential for proper 
functioning of cell membranes, lipoprotein metabolism and 
moreover for the regulation of cellular life cycle [3, 4]. PC is 
synthesized through the CDP-choline pathway and via the 
phosphatidylethanolamine N-methyltransferase (PEMT) de 
novo pathway. The CTP: phosphocholine cytidylyltransferase 
(CCT) catalyzes the key rate-limiting step in the CDP-choline 
pathway (Fig. 1) [3–5]. In human pregnancy, PEMT-phos-
phatidylcholine (vs phosphatidylcholine produced by the 
CDP-choline pathway) is preferentially partitioned from 
the maternal to the fetal compartment [6]. Thus, supple-
menting the maternal diet with extra choline during early 
pregnancy may increase supply of choline and DHA to the 
developing fetus. 
CHDH gene encodes choline dehydrogenase localized 
in mitochondria. Variations of this gene may result in sus-
ceptibility to choline deficiency. Choline dehydrogenase is 
involved in the subpathway that synthesizes betaine alde-
hyde from choline (cytochrome c reductase route). Choline 
is imported through one of several transporters and phos-
phorylation by choline kinase (CHK) occurs in the cyto-
plasm (Fig. 1) [7]. There are two isoforms of choline kinase 
— CHKα and CHKβ, with the α as a dominant isoform [8]. 
The CHKA gene which encodes choline kinase α is found at 
chromosome 11q13.2. CCT is the rate-controlling enzyme 
in the CDP-choline pathway and its activity is regulated 
by signals from the membrane that report on the relative 
PC abundance. Human PCYT1A (chromosome 3q29) and 
PCYT1B (chromosome Xp22.11) encode CCTα and CCTβ, 
respectively [9]. 
Given that pregnant women carrying genetic variants 
that increase choline requirements may be particularly 
susceptible to choline inadequacy during this reproduc-
tive state, we investigated the influence of CHKA, PCYT1A 
and CHDH genotypes on the risk of intrauterine fetal death 
(IUFD). Our study aimed at determining the incidence 
and genotype frequencies of CHKA rs7928739, PCYT1A 
rs712012, PCYT1A rs7639752, CHDH rs893363 and CHDH 
rs2289205 polymorphisms in 76 healthy mothers with 
IUFD of unknown origin occurrence (case mothers) and in 
215 healthy mothers of healthy children (control mothers). 
Additionally, tests for association of CHDH, PCYT1A and 
CHKA polymorphisms and evaluation of co-existence of 
analyzed genetic variants were performed.
MATERIAL AND METHODS
Study population
Peripheral blood samples from 76 healthy mothers with 
IUFD of unknown origin were obtained from the Department 
of Perinatology and Women’s Diseases, Poznan University of 
Medical Sciences. In addition, 215 mothers of healthy new-
borns born at term were used as controls. Patients with IUFD 
were enrolled to the study group within 2004–2014 year, 
and women to the control group — within 2012–2014 year. 
All women with improper fetal development, congenital 
malformations of the fetus, pregnancy connected diseases, 
placental and umbilical abnormalities, physical trauma dur-
ing pregnancy, chronic diseases, vegan or vegetarian diet 
were excluded from the study as well as from the control 
group. Additionally, women with a positive history of IUFD in 
previous pregnancies were excluded from the control group. 
Moreover, each women involved in the analysis declared 
taking folic acid at least 3 months before conception and 
up to the end of pregnancy. Gestational age of IUFD was 
established on the basis of the date of the last menstruation, 
regularity of periods and ultrasound examinations. The clini-
cal characteristic of the study and control groups is shown 
in Table 1. All participating women were Caucasian of Po- 
lish origin and were recruited from the same geographical 
region (Wielkopolska). The study protocols were approved 
by the local Ethics Committee. Written consent was obtained 
from all participants.
Genotyping by RFLP
Genotyping for polymorphisms in CHDH (rs893363 and 
rs2289205), PCYT1A (rs712012 and 7639752) and CHKA 
(rs7928739) was determined by polymerase chain reac-
tion-restriction fragment length polymorphism (PCR-RFLP) 
Figure 1. Choline pathways for phosphatidylcholine and betaine 
synthesis; PC — phosphatidylcholine; CHDH — choline dehydrogenase; 
CHK — choline kinase; CCT — CTP: phosphocholine cytidylyltransferase; 
DAG — diacylglycerol
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assay. To amplify the gene fragments harboring these poly-
morphisms, five sets of the following primers were designed: 
 Ū CHDH rs893363 5’ -GAGGAGCAACGTGGTGATCT- 3’ and 
5’ -CGAAGGAACCAGGAGGATAAG- 3’
 Ū CHDH rs2289205 5’ -CCACCTCAACCTCCAGTTGT- 3’ and 
5’ -GCAGCCATTCACTAACATGC- 3’
 Ū PCYT1A rs712012 5’ -GAGGGACAGAGGTCAAGGTG- 3’ 
and 5’ -AGTCACAAATCCCCTGAACG- 3’
 Ū PCYT1A rs7639752 5’ -CGCCCCTGTAGAGAACTGAC- 3’ 
and 5’ -ATATCCATAGCCCCAGGTGA- 3’
 Ū CHKA rs7928739 5’ -TGATTTCCAATGTCGAATCC- 3’ and 
5’ -TAAGTCAAAATGCCGCTCTG- 3’
The analyzed polymorphic variants were identified by 
appropriate restriction enzyme digestion. The digested PCR 
products were analyzed on a 2% agarose gel and stained 
with ethidium bromide for visualization under UV light.
Statistical analysis
The genotype and allele frequencies of the analyzed 
polymorphisms were compared between both groups 
of mothers using a case-control study design. Signifi- 
cance was evaluated by the Fisher exact test. Odds ratios 
(ORs) and 95% confidence intervals (CIs) were estimated 
using the GraphPad (Instant, USA) program. An online 
(http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl) 
program for deviation from the Hardy-Weinberg equilibrium 
was applied.
RESULTS
Table 2 presents genotype and allele distribution among 
mothers with IUFD and control mothers. As shown there 
were no statistically significant correlations between ana-
lyzed genetic variants and the incidence of IUFD. The fre-
quency of genotypes and alleles of studied polymorphisms 
was similar in both groups. Additionally, tests for association 
of PCYT1A, CHKA and CHDH polymorphisms in mothers with 
IUFD occurrence and control mothers was performed. The 
study revealed no association of single PCYT1A, CHKA and 
CHDH polymorphisms in analysed groups of women (Tab. 3).
While evaluating the co-existence of analysed poly-
morphisms statistically significant correlation was revealed. 
Co-existence of CHKA rs7928739 AC/CHDH rs2289205 AA 
genotypes was observed statistically more frequently in the 
study than in the control group (p = 0.031). 
DISCUSSION
Intrauterine fetal death is a serious obstetrical complica-
tion. It is thought that globally there are at least 3.2 million 
stillbirths per year [10]. Infections, problems related to the 
placenta and umbilical cord, congenital anomalies, maternal 
Table 1. The clinical characteristic of the study groups
IUFD
(n = 76)
Control group
(n = 215) p
Age (years)
Mean ± SD
Median
Min-max
30.46 ± 4.32
31
20–42
30.66 ± 4.66
31
17–46
0.74
Systolic pressure  
[mm Hg]
Mean ± SD
Median
Min-max
105.80 ± 11.46
100.00
90 - 140
103.53 ± 10.23
100,00
80–120
0.11
Diastolic pressure  
[mm Hg]
Mean ± SD
Median
Min-max
66.73 ± 10.57
60
55–120
65.79 ± 7.99
60
50–90
0.42
Height [cm]
Mean ± SD
Median
Min-max
165.84 ± 0.09
167
150–183
166.84 ± 5.71
167
151–184
0.30
Weight [kg]
Mean ± SD
Median
Min-max
62.01 ± 9.92
61
44–99
60.99 ± 10.56
59
45–114
0.46
BMI [kg/m2]
Mean ± SD
Median
Min-max
22.58 ± 3.59
21.61
18.03–38.67
21.89 ± 3.58
21.14
16.94–40.53
0.15
IUFD
One
Two or more
≤ 37 gw.
> 37 gw.
69
7
72
4
0
0
0
0
—
Gestational week of 
IUFD
Mean ± SD
Median
Min-max
30.02 ± 4.92
30
22–40
— —
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Table 2. Genotype and allele distribution among mothers with intrauterine fetal death incidence (IUFD case mothers) and control mothers
Polymorphism Group  of women
Genotype distribution absolute 
number (frequency)
Allele P 
 Valuea
TT TC CC T C T vs. C 
PCYT1A
rs712012
Control mothers 78(0.36)
107
(0.50)
30
(0.14)
263
(0.61)
167
(0.39) p = 1.00
Case mothers 26(0.34) 41 (0.54)
9 
(0.12)
93
(0.61)
59
(0.39)
AA AG GG A G A vs. G 
PCYT1A
rs7639752
Control mothers 49(0.23)
105
(0.49)
61
(0.28)
203
(0.47)
227
(0.53) p = 0.345
Case mothers 19(0.25) 41 (0.54) 16 (0.21)
79
(0.52)
73
(0.48)
AA AC CC A C A vs. C 
CHKA
rs7928739
Control mothers 72(0.33)
100
(0.47)
43
(0.20)
244
(0.57)
186
(0.43) p = 0.924
Case mothers 26(0.34) 35 (0.46) 15 (0.20)
87
(0.57)
65
(0.43)
TT TC CC T C T vs. C 
CHDH
rs893363
Control mothers 88(0.41)
97
(0.45)
30
(0.14)
273
(0.63)
157
(0.37) p = 0.558
Case mothers 27(0.36) 38 (0.50) 11 (0.14)
92
(0.60)
60
(0.40)
GG GA AA G A G vs. A 
CHDH
rs2289205
Control mothers 116(0.54)
86
(0.40)
13
(0.06)
318
(0.74)
112
(0.26) p = 1.00
Case mothers 43(0.57) 26 (0.34) 7 (0.09)
112
(0.74)
40
(0.26)
aFisher exact test
diseases and poor nutritional status have been reported 
to be the reasons of fetal death [11]. A number of investi-
gations, including autopsy, examination of the placenta, 
amniocentesis and tests on blood from the mother and 
child, have been recommended in the diagnostic evalua-
tion of IUFD [12–15]. The proportion of IUFDs in which no 
identifiable cause can be determined ranges from 12 to 
50% and may be related to environmental factors [16–18]. 
Notably, increased consumption of dietary choline during 
pregnancy can improve biomarkers of choline metabolism. 
For example, consumption of 930 versus 480 mg choline/day 
by third-trimester pregnant women led to higher circulating 
concentrations of several choline-derived methyl donors 
and restored choline partitioning between the CDP-choline 
and betaine pathways (which compete for choline as a sub-
strate) to a nonpregnant state [6, 19]. 
Research on the role of dietary factors in human repro-
duction is limited but intake of certain nutrients, particularly 
folate, could positively influence reproductive success [20]. 
Numerous studies carried out on pregnant women have 
mentioned increased levels of homocysteine (Hcy) in rela-
tion to all the clinical conditions where a vascular-placental 
Table 3. The tests for association* of CHDH, PCYT1A and CHKA polymorphisms in mothers with IUFD incidence and control mothers
Gene polymorphism
Risk allele C
CHDH
rs893363
[T] vs. [C] [TT] vs. [TC] [TT] vs. [CC] [TT] vs. [TC + CC]
OR = 1.134
CI = [0.776–1.658]
χ2 = 0.42 
p = 0.51625
OR = 1.277
CI = [0.721–2.261] 
χ2 = 0.70 
p = 0.40148
OR = 1.195
CI = [0.529–2.698]
χ2 = 0.18 
p = 0.66779
OR = 1.258
CI = [0.731–2.164]
χ2 = 0.69 
p = 0.40751
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Table 3 (cont.). The tests for association* of CHDH, PCYT1A and CHKA polymorphisms in mothers with IUFD incidence and control mothers
Gene polymorphism
Risk allele T
CHDH
rs893363
[C] vs. [T] [CC] vs. [TC] [CC] vs. [TT] [TT + TC] vs. [CC]
OR = 0.882
CI = [0.603–1.289]
χ2 = 0.42
p = 0.51625
OR = 1.068
CI = [0.487–2.345]
χ2 = 0.03
 p = 0.86893
OR = 0.837 
CI = [0.371–1.889]
χ2 = 0.18 
p = 0.66779
OR = 0.958 
CI = [0.454–2.021]
χ2 = 0.01 
p = 0.91079
Risk allele A
CHDH
rs2289205
[G] vs. [A] [GG] vs. [GA] [GG] vs. [AA] [GG] vs. [GA + AA]
OR = 1.014 
CI = [0.666–1.544]
χ2 = 0.00 
p = 0.94820
OR = 1.150 
CI = [0.649–2.036] 
χ2 = 0.23 
p = 0.63258
OR = 1.453 
CI = [0.543–3.883] 
χ2 = 0.56 
p = 0.45482
OR = 0.899 
CI = [0.531–1.523] 
χ2 = 0.16 
p = 0.69271
Risk allele G
CHDH
rs2289205
[A] vs. [G] [AA] vs. [GA] [AA] vs. [GG] [GG + GA] vs. [AA]
OR = 0.986 
CI = [0.648–1.501]
χ2 = 0.00 
p = 0.94820
OR = 0.561 
CI = [0.203–1.554]
χ2 = 1.26 
p = 0.26219
OR = 0.688 
CI = [0.258–1.840]
χ2 = 0.56 
p = 0.45482
OR = 0.634 
CI = [0.243–1.655]
χ2 = 0.88 
p = 0.34868
Risk allele C
PCYT1A
rs712012
[T] vs. [C] [TT] vs. [TC] [TT] vs. [CC] [TT] vs. [TC + CC]
OR = 0.999 
CI = [0.684–1.460]
χ2 = 0.00 
p = 0.99628
OR = 1.150 
CI = [0.649–2.036] 
χ2 = 0.23 
p = 0.63258
OR = 0.900 
CI = [0.378–2.142] 
χ2 = 0.06 
p = 0.81171
OR = 1.095 
CI = [0.632–1.897] 
χ2 = 0.10 
p = 0.74636
Risk allele T
PCYT1A
rs712012
[C] vs. [T] [CC] vs. [TC] [CC] vs. [TT] [TT + TC] vs. [CC]
OR = 1.001 
CI = [0.685–1.463]
χ2 = 0.00 
p = 0.99628
OR = 1.277 
CI = [0.558–2.921]
χ2 = 0.34 
 p = 0.56147
OR = 1.111 
CI = [0.467–2.644]
χ2 = 0.06 
p = 0.81171
OR = 1.207 
CI = [0.545–2.675]
χ2 = 0.22 
p = 0.64235
Risk allele G
PCYT1A
rs7639752
[A] vs. [G] [AA] vs. [AG] [AA] vs. [GG] [AA] vs. [AG + GG]
OR = 0.826 
CI = [0.571–1.197]
χ2 = 1.02 
p = 0.31236
OR = 1.007 
CI = [0.530–1.912] 
χ2 = 0.00 
p = 0.98294
OR = 0.676 
CI = [0.315–1.452] 
χ2 = 1.01 
p = 0.31454
OR = 0.886 
CI = [0.482–1.628] 
χ2 = 0.15 
p = 0.69563
Risk allele A
PCYT1A
rs7639752
[G] vs. [A] [GG] vs. [AG] [GG] vs. [AA] [AA + AG] vs. [GG]
OR = 1.210 
CI = [0.836–1.752]
χ2 = 1.02 
p = 0.31236
OR = 1.489 
CI = [0.771–2.875]
χ2 = 1.41 
p = 0.23455
OR = 1.478 
CI = [0.689–3.174]
χ2 = 1.01 
p = 0.31454
OR = 1.485 
CI = [0.794–2.778]
χ2 = 1.55 
p = 0.21373
Risk allele C
CHKA
rs7928739
[A] vs. [C] [AA] vs. [AC] [AA] vs. [CC] [AA] vs. [AC + CC]
OR = 0.980 
CI = [0.674–1.424]
χ2 = 0.01 
p = 0.91604
OR = 0.969 
CI = [0.537–1.750] 
χ2 = 0.01 
p = 0.91745
OR = 0.966 
CI = [0.461–2.023] 
χ2 = 0.01 
p = 0.92695
OR = 0.968 
CI = [0.557–1.682] 
χ2 = 0.01 
p = 0.90884
Risk allele A
CHKA
rs7928739
[C] vs. [A] [CC] vs. [AC] [CC] vs. [AA] [AA + AC] vs. [CC]
OR = 1.020 
CI = [0.702–1.483]
χ2 = 0.01 
p = 0.91604
OR = 1.003
CI = [0.497–2.026]
χ2 = 0.00 
p = 0.99259
OR = 1.035 
CI = [0.494–2.168]
χ2 = 0.01 
p = 0.92695
OR = 1.017
CI = [0.527–1.960]
χ2 = 0.00
p = 0.96063
*The tests for association were adapted from http://ihg.gsf.de/cgi-bin/hw/hwa1.pl 
CI — 95% confidence interval; OR — odds ratio
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pathology seems to be implicated, such as intrauterine 
growth retardation (IUGR), preeclampsia, placental abrup-
tion and IUFD [21]. Therefore it seems highly advisable to 
administer folic acid during the second and the third trimes-
ter of pregnancy in order to prevent hyperhomocysteinemia 
which in many cases could be responsible for the vascular 
damage [22]. Lower folate intake has been linked to reduced 
cell division, disrupted methylation reactions, and increased 
inflammatory cytokine production, oxidative stress levels, 
and apoptosis, all of which could subsequently affect the 
developing embryo [22]. Thus, the vascular effects related to 
folate deficiency might also increase the risk of spontaneous 
abortion and stillbirth. Another explanation is that low folate 
levels increase the incidence of neural tube defects (NTDs), 
and fetuses affected with neural tube defects are more com-
monly aborted spontaneously [23]. While plausible, NTDs 
are rare conditions and this could only explain a fraction of 
the association between low folate levels and spontaneous 
abortion. However, there are other nutritional factors that 
modify the NTD risk. Periconceptional diet rich in choline 
reduces NTD occurrence independently of folate intake [24].
As far as we now, this is the first study on correlation 
between maternal CHKA, PCYT1A and CHDH gene polymor-
phisms an the risk of intrauterine fetal death in the Polish 
population. Beside the basic aim of the study we wanted to 
highlight nowadays great meaning of nutrigenomics. Nu-
trigenomics or nutrigenetics, which concerns correlation 
between genes and diet is a great challenge of worldwide 
public health. It is very rapidly developing field of science 
which may influence changing science into practice in hu-
man nutrition. Thanks to exploring correlation between ge-
netic changes in metabolic pathways clinicians may be able 
to provide personalized nutrition recommendations. This is 
extremely important in case of pregnant women. 
Genetically conditioned changes in folate cycle influ-
ences the proper course of pregnancy. Because choline 
metabolism and folate metabolism crosses at the methyla-
tion of homocysteine, manipulations that limit folate avail-
ability also increase the use of choline in methylation pro-
cesses. Genetic differences in requirements for choline are 
due to single nucleotide polymorphisms (SNPs) of choline 
pathway [25]. But it is worth remarking that polymorphisms 
of genes involved in folate cycle also modifies the suscep-
tibility to choline deficiency. SNPs in few genes encoding 
enzymes of folate and choline cycle influence choline me-
tabolism and synthesis. It may result in increased choline 
dietary demand, especially during pregnancy and lacta-
tion. Choline deficiency may alter gene expression through 
the epigenetics mechanisms. This is another premise of 
the great meaning of nutrigenomics for worldwide public 
health. Correlation between nutrition and epigenetics has 
been already established [26, 27].
That is why we aimed to investigate polymorphisms of 
choline metabolism pathway in the group of women with 
a positive history of intrauterine fetal death. Despite the lack of 
correlation between analyzed in our research genetic variants 
and the incidence of IUFD we are deeply convinced about the 
need of further analysis of that issue. Thanks to that it might be 
possible to identify the subsets of population which differs in 
a requirement of a specific nutrient [28]. Nutrigenetic profiling 
will allow to identify subgroups which differs in nutrient re-
quirements and clarify interventions and recommendations. In 
a consequence, diet guidelines often suggesting unattainable 
intake of some food will no longer be necessary. 
It is also worth to remark some study limitations. We are 
aware of the need of measuring homocysteine concentra-
tion in both study and control group and comparing it to 
polymorphisms. But due to the long study timing some 
patients withdrew their consent to research (patients with 
IUFD were enrolled to the study within 2004–2014 year). 
Additionally, because of the inconstant concentration of ho-
mocysteine in the course of pregnancy in such small group 
of patient obtained results would not be reliable (in our 
study IUFD occurrence between 22–40 gestational week).
CONCLUSIONS
There is no correlation between single CHKA 
rs7928739, PCYT1A rs712012, PCYT1A rs7639752, CHDH 
rs893363 and CHDH rs2289205 polymorphisms and the 
incidence of intrauterine fetal death. However, revealed 
statistically significant difference between co-existence of 
CHKA rs7928739 AC/CHDH rs2289205 AA genotypes be-
tween study groups suggest the need of further analysis.
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